Precision Castparts Corp (PCP), which I first discussed on April 19, 2009 at a price of $61.92, continues to ascend, with the stock testing the $150 level, and I obviously still like the business model at this stage.

In fact, if you're in at/near $62, if you haven't already, now may be a good time to consider taking some profits with PCP.

However, other investors who can tolerate the risk can maintain their full position and go for an even bigger gain.

I'd also raise the sell/stop loss to $88 from $79 at this stage.

Analyst Upgrades

• Google (GOOG) to outperform from neutral at Wedbush.
• Nike (NKE) to buy from neutral at UBS.
• Apollo Group (APOL) to market perform from underperform at FBR Capital.
• JDSU (JDSU) to overweight from neutral at Piper Jaffray.
• NetApp (NTAP) to overweight from equal weight and Verigy (VRGY) to equal weight from underweight at Barclays.
• RSC Holdings (RRR) to outperform from neutral at RW Baird.
• Exelon (EXC) to buy from hold at Jefferies.
• Aon (AON) and Willis Group (WSH) to outperform from market perform at Keefe Bruyette.
• BMC Software (BMC) to outperform from neutral at Cowen.

Analyst Upgrades

• Piper Jaffray upgraded Red Hat (RHT) to overweight from neutral.
• Honeywell (HON) was upgraded to outperform from neutral at Cowen.
• Regal-Beloit (RBC) and Actuant (ATU) were upgraded to buy from hold at Jefferies.
• RW Baird upgraded MedAssets (MDAS) to outperform from neutral.
• Savvis (SVVS) was upgraded to outperform from market perform at William Blair.

As forecast in July, the correction in Precision Castparts Corp (PCP), which I first discussed on April 20, 2009 at a price of $61.92, ended after it held psychological support at $100, and the stock moved smartly higher.

However, if you missed the summer entry, don't fret: there's more upside ahead for PCP.

Precision's fiscal 2011 revenue should increase about 10-12%, with another healthy, 10-15% gain likely in fiscal 2012.

Further, much of that revenue rise will come from commercial airliner work. Precision is a major maker of jet engine components, and PCP will benefit as production continues to ramp-up in 2011.

As expected, the shares of Precision Castparts Corp (PCP), which I first discussed on April 20, 2009 at a price of $61.92, corrected earlier this year, in the spring, after rushing through $136, hence if you took some profits off the table at that juncture, it was prudent.

But now the correction appears to be over, and PCP, after a test of $100 has moved back above the key, 50-day moving average -- a bullish sign.

Precision's fiscal 2011 revenue should increase more than 10%, with another healthy gain likely in fiscal 2012.

Analyst upgrades:

• Oppenheimer upgraded Goldman Sachs (GS) to Outperform from Perform following the company's $550M settlement with the SEC. Opco has a $213 price target for Goldman shares. BofA/Merrill upgraded Goldman Sachs to Buy from Neutral and raised its price target to $182 from $160.
• Wells Fargo upgraded JP Morgan (JPM) to Outperform from Market Perform following the company's Q2 results citing valuation and lower credit costs. The firm keeps a valuation range for shares of $48-$51.
• Goldman upgraded Murphy Oil (MUR) to Buy from Neutral and has a $61 price target on the stock. The firm cites Murphy's Eagle Ford growth and valuation for the upgrade.
• Precision Cast (PCP) was upgraded to Outperform from Neutral at Credit Suisse.
• Pride International (PDE) was upgraded to Buy from Hold at Jefferies.
• BHP Billiton (BHP) was upgraded to Overweight from Neutral at HSBC.

Analyst Upgrades

• FBR Capital upgraded Microsoft (MSFT) to outperform from market perform, citing valuation and the ongoing corporate PC cycle refresh. The firm upped its target for shares to $32 from $31.
• Oppenheimer upgraded BP (BP) to outperform from perform with a $55 price target as it sees greater upside potential than downside risk from the oil spill.
• Wunderlich upgraded Stericycle (SRCL) to hold from sell and raised its target for shares to $50 from $42, citing the company's alliance with Republic Services (RSG).
• Illinois Tool Works (ITW) was upgraded to overweight from equal weight at Barclays.
• GameStop (GME) was upgraded to buy from neutral at Janney Montgomery.
• Fluor (FLR) was upgraded to buy from neutral at Goldman.

Precision Castparts (PCP), first discussed here on April 19, 2009, at a price of $61.92, has had an impressive run in a year -- it's up about 100%.

Hence, it's perfectly acceptable to take some profits off the table, at this juncture, with PCP.

However, those investors who can tolerate the risk can maintain their full position to go for an even bigger gain. The reason? Precision's 2011 revenue should increase more than 10%, and institutional investors are emphasizing that metric -- looking right past a likely 2010 revenue decline.

Air travel is on the rebound, and that's a major reason I'm reiterating mybuy rating for Precision Castparts Corp. (PCP), first recommended on April 20, 2009 at a price of $61.92. If you bought PCP in April 2009, an impressive 70%.

Precision is a major maker of jet engine components, and PCP will benefit as production ramps-up in FY2010: by most measures, an industrial bottom has occurred in the U.S. and global economies in Q3/Q4. Hence, rising demand coupled with the need to re-stock inventories of parts bodes well for Precision. The key revenue drivers: 1) emerging market economies that are modernizing their airline fleets and increasing fleet sizes and 2) Boeing's (BA) new 787 Dreamliner, which is undergoing test flights and is expected to enter service by the end of 2010.

With Precision Castparts Corp. (NYSE: PCP), as air travel goes, so go the profits, which is why I'm Reiterating my Buy rating for the company, first recommended on April 20, 2009, at a price of $61.92. If you bought PCP in April, you're up an impressive 50%.

Precision is a major maker of jet engine components, and PCP will benefit as engine orders ramp-up in FY2010. By most measures, an industrial bottom is occurring in the U.S. and global economies in Q3/Q4. Hence, rising demand coupled with the need to re-stock inventories of parts bodes well for Precision. The key revenue drivers: 1) emerging market economies that are modernizing their airline fleets and increasing fleet sizes and 2) Boeing's (NYSE: BA) new 787 Dreamliner, which should undergo its first test flight by the end of 2009.

The major revenue driver for Precision Castparts (NYSE: PCP) is up in the air, literally. Precision is a major maker of jet engine components, and although only modest growth is expected in the sector, due to moderating demand, PCP will benefit as production ramps-up in FY2010.

Therefore, I'm reiterating my Buy rating for Precision Castparts, first recommended on April 20, 2009 at a price of $61.92. If you purchased PCP at that time, you're up a nice 35%.

Readers of this space know that the investment bias is toward large-cap companies with demonstrated business models and who have a competitive advantage in established markets, preferably with a favorable, global trend as a support. And with the aforementioned in mind, Precision Castparts (NYSE: PCP) is worth a review.

Just call Precision Castparts a hybrid cyclical/defensive. The company is a large manufacturer of forged components for the power generation market, and in case one hasn't noticed, upgrades and expansion of power generation facilities should benefit from the Obama administration's initiatives to renovate the nation's electric grid, among other energy projects. Demand for industrial gas turbine parts should remain more than adequate.

Here are some highlights from this past week's earnings coverage from BloggingStocks:

• Alcoa Inc. (NYSE: AA) kicked off the new season with a larger-than-expected loss due to the economic slump.
• Allscripts-Misys Healthcare Solutions (NASDAQ: MDRX) reported better-than-expected Q2 earnings.
• Apollo Group Inc. (NASDAQ: APOL) share price soared after its strong Q1 earnings and guidance.
• Apple Inc. (NASDAQ: AAPL) earnings prospects without CEO Steve Jobs led to an analyst's downgrade.
• Autodesk Inc. (NASDAQ: ADSK) lowered its guidance as business slows at an unprcedented rate.
• Bank of America Corp. (NYSE: BAC) reported terrible Q4 results and receivbed additional TARP money.
• Bunge Ltd. (NYSE: BG) lowered its 2008 earnings estimate due to soft soybean commodity markets.
• Citigroup Inc. (NYSE: C) posted a much bigger-than-expected loss and said it would split in two.
• Coventry Health Care Inc. (NYSE: CVH) offered full-year guidance that was less than analysts expectations.
• CSX Corp. (NYSE: CSX) forecast Q4 earnings would come in below analysts' expectations.
• CVS Caremark Corp. (NYSE: CVS) increased its quarterly dividend despite the recent lowered guidance.
• Deutsche Bank (NYSE: DB) reported a net loss for Q4 and the full year, dragging down the sector.
• Genentech Inc. (NASDAQ: DNA) revenue and earnings surged but were lower than analysts estimated.
• Intel Corp. (NASDAQ: INTC) Q4 results were in line with low expectations as the gross margin declined.
• JPMorgan Chase & Co. (NYSE: JPM) reported a huge drop in Q4 earnings but it stayed in the black.
• Lexmark International Inc. (NYSE: LXK) slashed its Q4 outlook and announced job cuts.
• Pentair Inc. (NYSE: PNR) efforts to limit an earnings decline led to a buy recommendation.
• Precision Cast Corp. (NYSE: PCP) earnings prospects following the recent rally led to an analyst's downgrade.

Analyst upgrades:

• Baird upgraded Agilent (NYSE:A) to Outperform from Neutral and raised its target to $24 from $22. The firm expects Agilent's YoY order declines to bottom in 1H09 and for growth to return in 1Q10.
  
• Despite downgrading the Equity REIT industry to Underweight from Market Weight, Friedman Billings upgraded Home Properties (NYSE:HME) to Outperform from Market Perform to reflect the company's exposure to Washington, D.C. The firm thinks Washington has the potential for stable demand fundamentals.
  
• Keefe Bruyette raised Education Realty (NYSE:EDR) to Outperform from Market Perform to reflect the company's improved liquidity outlook.
• Cullen/Frost (NYSE:CFR) was upgraded to Overweight from Equal Weight at Barclays.
  
• Pfizer (NYSE:PFE) was raised to Neutral from Sell at Goldman.
  
• FPIC Insurance (NASDAQ:FPIC) was lifted at Piper Jaffray to Buy from Neutral.

Analyst downgrades:

• Credit Suisse downgraded Deutsche Telekom (NYSE:DT) to Neutral from Outperform and France Telecom (NYSE:FTE) to Underperform from Neutral in conjunction with cutting the European Telecommunications Services sector to Market Weight from Overweight.
  
• Goldman downgraded Harley-Davidson (NYSE:HOG) to Sell from Neutral and added shares to its Conviction Sell List. The firm, which lowered its target to $11 from $30, said HOG shares do not fully reflect the impact from unprecedented headwinds in global luxury motorcycle demand and credit.
  
• Jefferies downgraded Precision Cast (NYSE:PCP) to Hold from Buy following the recent rally as they believe near-term EPS growth will be challenging. The firm lowered its target to $72 from $75.
• AutoZone (NYSE:AZO) was downgraded to Market Perform from Outperform at Bernstein.
• Tenneco (NYSE:TEN) was cut to Market Perform from Outperform at Wachovia.
• Burlington Northern (NYSE:BNI) was lowered to Underweight from Equal Weight at Morgan Stanley.
• Friedman Billings downgraded the Equity REIT sector to Underweight from Market Weight.

Analyst initiations:

• Ladenburg initiated Pentair (NYSE:PNR) with a Buy rating and $32 target. The firm believes the company's cost reduction and growth strategies will limit earnings declines from weak end markets.
  
• Fiat (Other OTC:FIATY) was initiated with a Hold rating at ING Group.
  
• Raymond James resumed coverage of Tailsman Energy (NYSE:TLM) with a Market Perform rating.

Analyst upgrades:

• Jefferies upgraded shares of Genentech (NYSE: DNA) to Buy from Hold and raised its target to $100 from $95 on increased likelihood of an acquisition after Roche (OTC: RHHBY) reaffirmed commitment to its $100/share offer.
  
• Baird expects Broadcom (NASDAQ: BRCM) to gain market share in 2009 in mobile phones, IPTVs, and digital TVs. Shares were upgraded to Outperform from Neutral.
  
• Keefe Bruyette upgraded shares of Torchmark (NYSE: TMK) to Outperform from Market Perform as they see limited earnings risk and an attractive risk/reward.
• Apple (NASDAQ: AAPL) was raised to Buy from Add at Calyon.
  
• Tellabs (NASDAQ: TLAB) was upgraded to Buy from Neutral at UBS and to Hold from Underperform at Jefferies.
  
• Goldman upgraded AK Steel (NYSE: AKS) to Neutral from Sell and Steel Dynamics (NASDAQ: STLD) to Buy from Neutral.

Analyst downgrades: